IQIRVO vs MITIGARE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. IQIRVO and MITIGARE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IQIRVO	MITIGARE
Rating	New	72/100
Pharmacy pays	—	~$3.90 /30
Type	RX	RX
Active ingredient	ELAFIBRANOR	COLCHICINE
Manufacturer	Ipsen	Hikma
Dosage forms	Tablet	Capsule
Drug class	—	Alkaloid
Boxed warning	None	None
Half-life	—	about 27 to 31 hours (the label gives mean elimination half-lives of 26.6 to 31.2 hours in young healthy volunteers on 0.6 mg twice daily)
Treats	Biliary Liver Cirrhosis	Amyloidosis, Gout, Biliary Liver Cirrhosis

iqirvo mitigare

Rating

New

72/100

Pharmacy pays

—

~$3.90 /30

Type

Active ingredient

ELAFIBRANOR

COLCHICINE

Manufacturer

Ipsen

Hikma

Dosage forms

Tablet

Capsule

Drug class

—

Alkaloid

Boxed warning

None

Half-life

—

about 27 to 31 hours (the label gives mean elimination half-lives of 26.6 to 31.2 hours in young healthy volunteers on 0.6 mg twice daily)

Treats

Biliary Liver Cirrhosis

Amyloidosis, Gout, Biliary Liver Cirrhosis

Frequently asked questions

What is the difference between Iqirvo and Mitigare?

Iqirvo contains Elafibranor, while Mitigare contains Colchicine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.